NCT07451860Not yet recruiting
Chronic Total Occlusion and Triglyceride-Glucose Index
The Role of the Triglyceride-Glucose Index in Determining the Risk of Chronic Total Occlusion in Coronary Artery Disease
Source: ClinicalTrials.gov · Last updated 5 Mar 2026
Brief summary (registry, in English)
We retrospectively analyzed 200 CAD patients undergoing coronary angiography between 2026-2027. Patients were grouped by CTO presence. Clinical and laboratory parameters were compared, and logistic regression was performed to identify independent predictors.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 28 Feb 2026
- Start date
- 15 Mar 2026
- Primary completion date
- 15 Jul 2026
- Lead sponsor
- Kırıkkale University
- Diseases
- Coronary artery disease
- NCT number
- NCT07451860
What you commit to
- Study type: Observational
- Planned participants: 200
- From 15 Mar 2026 to the primary completion date, 15 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients \<18 years of age, history of atrial fibrillation, pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease, obesity (BMI \>30 kg/m²), inaccessible patient records
Who the study is looking for
- Adults ≥18 years of age, patients undergoing coronary angiography, non-obese individuals
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kırıkkale University Coordinator of this site? Confirm its status | Kirikkale | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.